{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["ALDH", "Breast cancer stem cells", "CD44", "Cytotoxicity", "MMPs", "Trastuzumab"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33471244", "DateCompleted": {"Year": "2021", "Month": "12", "Day": "31"}, "DateRevised": {"Year": "2021", "Month": "12", "Day": "31"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "01", "Day": "20"}], "Language": ["eng"], "ELocationID": ["10.1007/s10238-021-00685-0"], "Journal": {"ISSN": "1591-9528", "JournalIssue": {"Volume": "21", "Issue": "3", "PubDate": {"Year": "2021", "Month": "Aug"}}, "Title": "Clinical and experimental medicine", "ISOAbbreviation": "Clin Exp Med"}, "ArticleTitle": "Response to trastuzumab and investigation of expression profiles of matrix metalloproteinase-related proteins in primary breast cancer stem cells.", "Pagination": {"StartPage": "447", "EndPage": "456", "MedlinePgn": "447-456"}, "Abstract": {"AbstractText": ["Breast cancer (BC) is the leading cause of cancer deaths in women. One of the reasons for the failure of BC treatment is reportedly the ineffectiveness of chemotherapeutic drugs against breast cancer stem-like cells (BCSCs). HER2 receptors have an important role in the self-renewal of BCSCs. Matrix metalloproteinase (MMP) and cytokine levels were found to be higher in BCSCs, which demonstrates their potential metastatic capacity. Therefore, the aim of this study was to evaluate the response of BCSCs to trastuzumab and to investigate the MMP levels in primary breast cancer cells and HER2<sup>+</sup> BCSCs. Tumour tissue samples were obtained during surgical intervention from ten breast cancer patients, and primary culture cells were established from these tissues. Four major molecular subgroups were sorted from the primary culture: HER2<sup>+</sup> BCSCs (CD44<sup>+</sup>CD24<sup>-</sup>HER2<sup>+</sup>), HER2<sup>-</sup> BCSCs (CD44<sup>+</sup>CD24<sup>-</sup>HER2<sup>-</sup>), HER2<sup>-</sup> primary culture cells (CD44<sup>+</sup>CD24<sup>+</sup>HER2<sup>-</sup>) and triple positive primary culture cells (CD44<sup>+</sup>CD24<sup>+</sup>HER2<sup>+</sup>). These cells were cultured and treated with trastuzumab, paclitaxel, carboplatin, and the combination of those three drugs for 96\u00a0h. Cellular responses to these drugs were determined by XTT cytotoxicity test. MMPs and cytokine array analysis showed that MMPs and TIMP-1, TIMP-2 proteins were expressed more in HER2<sup>+</sup> BCSCs than in primary culture. HER2<sup>-</sup> BCSCs were more resistant to drugs than HER2<sup>+</sup> BCSCs. Our findings suggest that the presence of HER2<sup>-</sup> BCSCs may be responsible for primary trastuzumab resistance in HER2<sup>+</sup> BC cell population. Further studies investigating the function of MMPs are needed for drug targeting of BCSCs."]}, "AuthorList": [{"Identifier": ["0000-0003-1571-2986"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Nanotechnology and Advanced Materials, Advanced Technology Research and Application Center, Selcuk University, Konya, Turkey."}], "LastName": "Koygun", "ForeName": "Gozde Kayadibi", "Initials": "GK"}, {"Identifier": ["0000-0002-7300-4075"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Meram Vocational School, Medicinal and Aromatic Plants Program, Necmettin Erbakan University, Konya, Turkey."}], "LastName": "Kars", "ForeName": "Meltem Demirel", "Initials": "MD"}, {"Identifier": ["0000-0003-3028-3112"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Medicine, Department of Pediatric Immunology and Allergy, Selcuk University, Konya, Turkey."}], "LastName": "Emsen", "ForeName": "Ayca", "Initials": "A"}, {"Identifier": ["0000-0002-9807-2605"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Medicine, Department of Pediatric Immunology and Allergy, Selcuk University, Konya, Turkey."}], "LastName": "Artac", "ForeName": "Hasibe", "Initials": "H"}, {"Identifier": ["0000-0003-1560-3034"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Meram Faculty of Medicine, Department of General Surgery, Necmettin Erbakan University, Konya, Turkey."}], "LastName": "Aksoy", "ForeName": "Faruk", "Initials": "F"}, {"Identifier": ["0000-0001-8789-8199"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Meram Faculty of Medicine, Department of General Surgery, Necmettin Erbakan University, Konya, Turkey."}], "LastName": "Cakir", "ForeName": "Murat", "Initials": "M"}, {"Identifier": ["0000-0003-3066-8776"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Meram Faculty of Medicine, Department of Pathology, Necmettin Erbakan University, Konya, Turkey."}], "LastName": "Tavli", "ForeName": "Lema", "Initials": "L"}, {"Identifier": ["0000-0003-2335-3354"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Meram Faculty of Medicine, Department of Medical Oncology, Necmettin Erbakan University, Konya, Turkey. mehmetartac@yahoo.com."}], "LastName": "Artac", "ForeName": "Mehmet", "Initials": "M"}], "GrantList": [{"GrantID": "113S559", "Agency": "T\u00fcrkiye Bilimsel ve Teknolojik Ara\u015ftirma Kurumu", "Country": ""}, {"GrantID": "15201017", "Agency": "Sel\u00e7uk \u00dcniversitesi", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Italy", "MedlineTA": "Clin Exp Med", "NlmUniqueID": "100973405", "ISSNLinking": "1591-8890"}, "ChemicalList": [{"RegistryNumber": "BG3F62OND5", "NameOfSubstance": "Carboplatin"}, {"RegistryNumber": "EC 2.7.10.1", "NameOfSubstance": "ERBB2 protein, human"}, {"RegistryNumber": "EC 2.7.10.1", "NameOfSubstance": "Receptor, ErbB-2"}, {"RegistryNumber": "EC 3.4.24.-", "NameOfSubstance": "Matrix Metalloproteinases"}, {"RegistryNumber": "P188ANX8CK", "NameOfSubstance": "Trastuzumab"}, {"RegistryNumber": "P88XT4IS4D", "NameOfSubstance": "Paclitaxel"}], "MeshHeadingList": [{"QualifierName": ["drug therapy", "genetics", "metabolism"], "DescriptorName": "Breast Neoplasms"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Carboplatin"}, {"QualifierName": [], "DescriptorName": "Drug Resistance, Neoplasm"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Flow Cytometry"}, {"QualifierName": ["drug effects"], "DescriptorName": "Gene Expression Regulation, Neoplastic"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism"], "DescriptorName": "Matrix Metalloproteinases"}, {"QualifierName": [], "DescriptorName": "Neoplastic Stem Cells"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Paclitaxel"}, {"QualifierName": [], "DescriptorName": "Primary Cell Culture"}, {"QualifierName": ["genetics"], "DescriptorName": "Receptor, ErbB-2"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Trastuzumab"}, {"QualifierName": [], "DescriptorName": "Tumor Cells, Cultured"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Cojoc M, M\u00e4bert K, Muders MH, Dubrovska A. A role for cancer stem cells in therapy resistance: cellular and molecular mechanisms. Semin Cancer Biol. 2015;31:16\u201327.", "ArticleIdList": ["24956577"]}, {"Citation": "Sheng Y, Hu R, Zhang Y, Luo W. MicroRNA-4317 predicts the prognosis of breast cancer and inhibits tumor cell proliferation, migration, and invasion. Clin Exp Med. 2020;20:417\u201325.", "ArticleIdList": ["32279128"]}, {"Citation": "Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A. 2003;100:3983\u20138.", "ArticleIdList": ["12629218", "153034"]}, {"Citation": "Liu S, Cong Y, Wang D, Sun Y, Deng L, Liu Y, et al. Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts. Stem Cell Rep. 2014;2:78\u201391."}, {"Citation": "Korkaya H, Paulson A, Iovino F, Wicha MS. HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion. Oncog NIH Public Access. 2008;27:6120\u201330."}, {"Citation": "Trastuzumab A, Ithimakin S, Day KC, Malik F, Zen Q, Dawsey SJ, et al. HER2 drives luminal breast cancer stem cells in the absence of HER2 amplification: implications for efficacy of. Cancer Res. 2013;73:1635\u201346."}, {"Citation": "Li Y, Chu J, Feng W, Yang M, Zhang Y, Zhang Y, et al. EPHA5 mediates trastuzumab resistance in HER2-positive breast cancers through regulating cancer stem cell-like properties. FASEB J. 2019;33:4851\u201365.", "ArticleIdList": ["30620624"]}, {"Citation": "Wall ME, Wani MC. Camptothecin and taxol: from discovery to clinic. J Ethnopharmacol. 1996;51:239\u201354.", "ArticleIdList": ["9213622"]}, {"Citation": "Conklin KA. Cancer chemotherapy and antioxidants. J Nutr. 2004;134:3201S-3204S.", "ArticleIdList": ["15514307"]}, {"Citation": "Jiang H, Rugo HS. Human epidermal growth factor receptor 2 positive (HER2+) metastatic breast cancer: how the latest results are improving therapeutic options. Ther Adv Med Oncol. 2015;7:321\u201339.", "ArticleIdList": ["26557900", "4622301"]}, {"Citation": "Chang JC, Wooten EC, Tsimelzon A, Hilsenbeck SG, Gutierrez MC, Tham Y-L, et al. Patterns of resistance and incomplete response to docetaxel by gene expression profiling in breast cancer patients. J Clin Oncol. 2005;23:1169\u201377.", "ArticleIdList": ["15718313"]}, {"Citation": "Li X, Lewis MT, Huang J, Gutierrez C, Osborne CK, Wu M-F, et al. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer Inst. 2008;100:672\u20139.", "ArticleIdList": ["18445819"]}, {"Citation": "Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, Coradini D, et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res. 2005;65:5506\u201311.", "ArticleIdList": ["15994920"]}, {"Citation": "Dhillon J, Astanehe A, Lee C, Fotovati A, Hu K, Dunn SE. The expression of activated Y-box binding protein-1 serine 102 mediates trastuzumab resistance in breast cancer cells by increasing CD44<sup>+</sup> cells. Oncogene. 2010;29:6294\u2013300.", "ArticleIdList": ["20802512"]}, {"Citation": "Chen W, Qin Y, Liu S. Cytokines, breast cancer stem cells (BCSCs) and chemoresistance. Clin Transl Med. 2018;7:27.", "ArticleIdList": ["30175384", "6119679"]}, {"Citation": "Wee P, Wang Z. Epidermal growth factor receptor cell proliferation signaling pathways. Cancers (Basel). 2017;9:52."}, {"Citation": "Bouhniz OE, Zaied S, Naija L, Bettaieb I, Rahal K, Driss M, et al. Association between HER2 and IL-6 genes polymorphisms and clinicopathological characteristics of breast cancer: significant role of genetic variability in specific breast cancer subtype. Clin Exp Med. 2020;20:427\u201336.", "ArticleIdList": ["32372374"]}, {"Citation": "Yousef EM, Tahir MR, St-Pierre Y, Gaboury LA. MMP-9 expression varies according to molecular subtypes of breast cancer. BMC Cancer. 2014;14:609.", "ArticleIdList": ["25151367", "4150970"]}, {"Citation": "Page-McCaw A, Ewald AJ, Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol. 2007;8:221\u201333.", "ArticleIdList": ["17318226", "2760082"]}, {"Citation": "Phillips TM, McBride WH, Pajonk F. The response of CD24<sup>-/low</sup>/CD44<sup>+</sup> breast cancer-initiating cells to radiation. J Natl Cancer Inst. 2006;98:1777\u201385.", "ArticleIdList": ["17179479"]}, {"Citation": "Leinonen T, Pirinen R, B\u00f6hm J, Johansson R, Ropponen K, Kosma V-M. Expression of matrix metalloproteinases 7 and 9 in non-small cell lung cancer: relation to clinicopathological factors, \u03b2-catenin and prognosis. Lung Cancer. 2006;51:313\u201321.", "ArticleIdList": ["16423426"]}, {"Citation": "Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, et al. Design and synthesis of piperazine-based matrix metalloproteinase inhibitors. J Med Chem. 2000;43:369\u201380.", "ArticleIdList": ["10669564"]}, {"Citation": "Birkedal-Hansen H, Moore WGI, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med. 1993;4:197\u2013250.", "ArticleIdList": ["8435466"]}, {"Citation": "Yokoyama M, Ochi K, Ichimura M, Mizushima T, Shinji T, Koide N, et al. Matrix metalloproteinase-2 in pancreatic juice for diagnosis of pancreatic cancer. Pancreas. 2002;24:344\u20137.", "ArticleIdList": ["11961486"]}, {"Citation": "Mehner C, Hockla A, Miller E, Ran S, Radisky DC, Radisky ES. Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer. Oncotarget. 2014;5:2736\u201349.", "ArticleIdList": ["24811362", "4058041"]}, {"Citation": "Pham P V, Vu BT, Chinh Phan NL, Duong TT, Vuong TG, Thuy Nguyen GD, et al. Isolation of breast cancer stem cells by single-cell sorting. In: Ceccherini-Nelli L, Matteoli B, editors. Biomedical tissue culture. IntechOpen; 2012. p. 59\u201372."}, {"Citation": "Tirino V, Desiderio V, Paino F, Papaccio G, De Rosa M. Methods for cancer stem cell detection and isolation. Methods Mol Biol. 2012;879:513\u201329.", "ArticleIdList": ["22610581"]}, {"Citation": "Sheridan C, Kishimoto H, Fuchs RK, Mehrotra S, Bhat-Nakshatri P, Turner CH, et al. CD44+/CD24-breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. Breast Cancer Res. 2006;8:R59.", "ArticleIdList": ["17062128", "1779499"]}, {"Citation": "Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell. 2006;10:515\u201327.", "ArticleIdList": ["17157791", "2730521"]}, {"Citation": "Naor D, Wallach-Dayan SB, Zahalka MA, Sionov RV. Involvement of CD44, a molecule with a thousand faces, in cancer dissemination. Semin Cancer Biol. 2008;18:260\u20137.", "ArticleIdList": ["18467123"]}, {"Citation": "Oliveras-Ferraros C, Vazquez-Martin A, Martin-Castillo B, Cuf\u00ed S, Barco SD, Lopez-Bonet E, et al. Dynamic emergence of the mesenchymal CD44<sup>pos</sup>CD24<sup>neg/low</sup> phenotype in HER2-gene amplified breast cancer cells with de novo resistance to trastuzumab (Herceptin). Biochem Biophys Res Commun. 2010;397:27\u201333.", "ArticleIdList": ["20470755"]}, {"Citation": "Greve B, Kelsch R, Spaniol K, Eich HT, G\u00f6tte M. Flow cytometry in cancer stem cell analysis and separation. Cytom Part A. 2012;81(4):284\u201393."}, {"Citation": "Honeth G, Bendahl P, Ringn\u00e9r M, Saal LH, Gruvberger-Saal SK, L\u00f6vgren K, et al. The CD44+/CD24- phenotype is enriched in basal-like breast tumors. Breast Cancer Res. 2008;10:R53.", "ArticleIdList": ["18559090", "2481503"]}, {"Citation": "Ginestier C, Korkaya H, Dontu G, Birnbaum D, Wicha MS, Charafe-Jauffret E. The cancer stem cell: the breast cancer driver. Medecine/Sciences. 2007;23:1133\u20139."}, {"Citation": "Morimoto K, Kim SJ, Tanei T, Shimazu K, Tanji Y, Taguchi T, et al. Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression. Cancer Sci. 2009;100:1062\u20138.", "ArticleIdList": ["19385968"]}, {"Citation": "Vassalli G. Aldehyde dehydrogenases: not just markers, but functional regulators of stem cells. Stem Cells Int Stem Cells Int. 2019;2019:3904645.", "ArticleIdList": ["30733805"]}, {"Citation": "Magnifico A, Albano L, Campaner S, Delia D, Castiglioni F, Gasparini P, et al. Tumor-initiating cells of HER2-positive carcinoma cell lines express the highest oncoprotein levels and are sensitive to trastuzumab. Clin cancer Res. 2009;15:2010\u201321.", "ArticleIdList": ["19276287"]}, {"Citation": "Mohammadian H, Sharifi R, Rezanezhad Amirdehi S, Taheri E, Babazadeh BA. Matrix metalloproteinase MMP1 and MMP9 genes expression in breast cancer tissue. Gene Rep. 2020;21:100906."}, {"Citation": "Olivares-Urbano MA, Gri\u00f1\u00e1n-Lis\u00f3n C, R\u00edos-Arrabal S, Artacho-Cord\u00f3n F, Torralbo AI, L\u00f3pez-Ruiz E, et al. Radiation and stemness phenotype may influence individual breast cancer outcomes: the crucial role of MMPs and microenvironment. Cancers (Basel). 2019;11:1781", "ArticleIdList": ["6896076"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "10", "Day": "23"}, {"Year": "2021", "Month": "1", "Day": "12"}, {"Year": "2021", "Month": "1", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "1", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "1", "Day": "20", "Hour": "12", "Minute": "24"}], "PublicationStatus": "ppublish", "ArticleIdList": ["33471244", "10.1007/s10238-021-00685-0", "10.1007/s10238-021-00685-0"]}}], "PubmedBookArticle": []}